Google
CNTN — CANTON STRATEGIC HOLDINGS, INC. (Healthcare >> Biotechnology)
CNTN FAQ
What is CNTN's ROE?
CANTON STRATEGIC HOLDINGS, INC. reports a Return on Equity (ROE) of -17.18%.
What is CNTN's dividend yield?
CANTON STRATEGIC HOLDINGS, INC. offers a dividend yield of 0.00%.
What is CNTN's Deepscope Quality Score?
Deepscope rates CNTN's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CNTN?
Deepscope's AI Timing Score for CNTN is 51 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CNTN belong to?
CANTON STRATEGIC HOLDINGS, INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 3.21
Price
0.12
(3.88%)
Day Change
|
|
|---|
CNTN, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
ROEが昨年度比で低い
ROAがROEに比べて低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 95 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 3.21 |
| PBV / Sector |
0.46 / 4.90
GREAT
|
| Earning Per Share | -1.20 |
| PE / Sector |
N/A / 18.25
|
| PEG or PE/Growth / Sector |
N/A / 0.62
|
| Average 1M Daily Value |
2.40 M
GREAT
|
| Average 1W Daily Value |
2.95 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-16 09:58:47 |
| Symbol | CNTN |
| Name | CANTON STRATEGIC HOLDINGS, INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 69.80 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 215.70 / 8,995.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 34 Shrewsbury Avenue, Red Bank, NJ, United States, 07701
Phone: 732 889 3111
Website: https://www.cantonstrategic.com
Sector: Healthcare >> Biotechnology
Description: Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology. The company is involved in the operation of Canton Coin-centric digital asset treasury strategies, including validator operations and network participation; application support and strategic investments; collaboration and ecosystem advancement; capital raising and treasury expansion; token management - locking, lending, and options; Canton Foundation; and governance and risk management. It also researches and develops GV104, a buccal film formulation of nalmefene for the treatment of respiratory depression and prophylactic protection against synthetic opioid exposure in military and first responders; and GV023, an oral anti-tumor necrosis factor-alpha monoclonal antibody that addresses critical limitation of IV gold standard for the treatment of repeated intravenous infusions. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is headquartered in Red Bank, New Jersey.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
